Impact of patient body habitus on image quality and quantitative value in bone SPECT/CT.


Journal

Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 12 10 2021
accepted: 19 04 2022
pubmed: 12 5 2022
medline: 28 5 2022
entrez: 11 5 2022
Statut: ppublish

Résumé

The first edition of guidelines for standardization of bone single photon emission computed tomography (SPECT) imaging was published in 2017, and the optimization and standardization are widely promoted. To the purpose, clarification of the factors related to image quality and quantitative values and their influence are required. The present study aimed to clarify and optimize the influence of patient body habitus on image quality and quantitative values in bone SPECT/CT. National Electrical Manufacturers Association body phantom (S-size) and custom-made large body phantoms (M-size and L-size) that simulate the abdomens of Japanese patients weighing 60, 80, and 100 kg, were used. Each phantom was filled with Image quality in the 300 s acquisition showed that values of Q Patient body habitus significantly affects image quality and decreases the quantitative value in bone SPECT/CT. For the optimization, extend acquisition time according to the patient body habitus is effective for image quality. And for the standardization, it is important to achieve imaging conditions that meet the Japanese bone SPECT guidelines criteria to ensure adequate detectability.

Identifiants

pubmed: 35543916
doi: 10.1007/s12149-022-01746-4
pii: 10.1007/s12149-022-01746-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

586-595

Informations de copyright

© 2022. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.

Références

Palmedo H, Marx C, Ebert A, Kreft B, Ko Y, Türler A, et al. Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. Eur J Nucl Med Mol Imaging. 2014;41:59–67.
doi: 10.1007/s00259-013-2532-6
Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, et al. A prospective study comparing 99mTc-hydroxyethylene-diphosphonate planar bone scintigraphy and whole-body SPECT/CT with18F-fluoride PET/CT and18F-fluoride PET/MRI for diagnosing bone metastases. J Nucl Med. 2017;58:1778–85.
doi: 10.2967/jnumed.116.189183
Zeintl J, Vija AH, Yahil A, Hornegger J, Kuwert T. Quantitative accuracy of clinical 99mTc SPECT/CT using ordered-subset expectation maximization with 3-dimensional resolution recovery, attenuation, and scatter correction. J Nucl Med. 2010;51:921–8.
doi: 10.2967/jnumed.109.071571
Kuji I, Yamane T, Seto A, Yasumizu Y, Shirotake S, Oyama M. Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer. Eur J Hybrid Imaging. 2017;1:1–16.
doi: 10.1186/s41824-017-0006-y
Qi N, Meng Q, You Z, Chen H, Shou Y, Zhao J. Standardized uptake values of 99m Tc-MDP in normal vertebrae assessed using quantitative SPECT/CT for differentiation diagnosis of benign and malignant bone lesions. BMC Med Imaging. 2021;21:39.
doi: 10.1186/s12880-021-00569-5
Umeda T, Koizumi M, Fukai S, Miyaji N, Motegi K, Nakazawa S, et al. Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients. Ann Nucl Med. 2018;32:105–13.
doi: 10.1007/s12149-017-1224-x
Dickson J, Ross J, Vöö S. Quantitative SPECT: the time is now. EJNMMI Phys. 2019;6:1–7.
doi: 10.1186/s40658-019-0241-3
Miwa K, Matsutomo N, Ichikawa H, Kikuchi A, Shimada H, Narita A, et al. Japanese guideline 1.0 for the bone SPECT data acquisition protocol. Jpn J Nucl Med Tech. 2017;35:517–30.
Cachovan M, Vija AH, Hornegger J, Kuwert T. Quantification of 99mTc-DPD concentration in the lumbar spine with SPECT/CT. EJNMMI Res. 2013;3:1–8.
doi: 10.1186/2191-219X-3-45
Kaneta T, Ogawa M, Daisaki H, Nawata S, Yoshida K, Inoue T. SUV measurement of normal vertebrae using SPECT/CT with Tc-99m methylene diphosphonate. Am J Nucl Med Mol Imaging. 2016;6:262–8.
pubmed: 27766184 pmcid: 5069278
Huang K, Feng Y, Liu D, Liang W, Li L. Quantification evaluation of 99mTc-MDP concentration in the lumbar spine with SPECT/CT: compare with bone mineral density. Ann Nucl Med. 2020;34:136–43.
doi: 10.1007/s12149-019-01425-x
Nakahara T, Daisaki H, Yamamoto Y, Iimori T, Miyagawa K, Okamoto T, et al. Use of a digital phantom developed by QIBA for harmonizing SUVs obtained from the state-of-the-art SPECT/CT systems: a multicenter study. EJNMMI Res. 2017;7:53.
doi: 10.1186/s13550-017-0300-5
Tsutsui Y, Daisaki H, Akamatsu G, Umeda T, Ogawa M, Kajiwara H, et al. Multicentre analysis of PET SUV using vendor-neutral software: the Japanese harmonization technology (J-Hart) study. EJNMMI Res. 2018;8:1–10.
doi: 10.1186/s13550-018-0438-9
Daisaki H, Tateishi U, Terauchi T, Tatsumi M, Suzuki K, Shimada N, et al. Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma. Ann Nucl Med. 2013;27:225–32.
doi: 10.1007/s12149-012-0676-2
Fukukita H, Suzuki K, Matsumoto K, Terauchi T, Daisaki H, Ikari Y, et al. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of version 2.0. Ann Nucl Med. 2014;28(693):705.
Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology. 1999;213:521–5.
doi: 10.1148/radiology.213.2.r99nv37521
Kim CK, Gupta NC, Chandramouli B, Alavi A. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med. 1994;35:164–7.
pubmed: 8271040
Taniguchi T, Akamatsu G, Kasahara Y, Mitsumoto K, Baba S, Tsutsui Y, et al. Improvement in PET/CT image quality in overweight patients with PSF and TOF. Ann Nucl Med. 2015;29:71–7.
doi: 10.1007/s12149-014-0912-z
Shimada N, Daisaki H, Murano T, Terauchi T, Shinohara H, Moriyama N. Optimization of the scan time is based on the physical index in FDG-PET/CT. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2011;67:1259–66.
doi: 10.6009/jjrt.67.1259
Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
doi: 10.1038/bmt.2012.244
Peters SMB, van der Werf NR, Segbers M, van Velden FHP, Wierts R, Blokland KJAK, et al. Towards standardization of absolute SPECT/CT quantification: a multi-center and multi-vendor phantom study. EJNMMI Phys. 2019;69(1):29.
doi: 10.1186/s40658-019-0268-5
Kangasmaa TS, Constable C, Sohlberg AO. Quantitative bone SPECT/CT reconstruction utilizing anatomical information. EJNMMI Phys EJNMMI Physics. 2021;8:1–14.
doi: 10.1186/s40658-020-00344-5
Hayashi N, Tokorodani R, Kenda S, Ogasawara D, Yabe F, Ito K. Determination of bone SPECT image reconstruction conditions in the head and neck region. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2021;77:700–9.
doi: 10.6009/jjrt.2021_JSRT_77.7.700
Onishi H, Motomura N, Fujino K, Natsume T, Haramoto Y. Quantitative performance of advanced resolution recovery strategies on SPECT images: evaluation with use of digital phantom models. Radiol Phys Technol. 2013;6:42–53.
doi: 10.1007/s12194-012-0168-z
Maeda Y, Nagaki A, Komi Y, Abe N, Kashimura S. Evaluation of resolution correction in single photon emission computed tomography reconstruction method using a body phantom: study of three different models. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2015;71:1070–9.
doi: 10.6009/jjrt.2015_JSRT_71.11.1070
Miyaji N, Miwa K, Motegi K, Yamashita K, Terauchi T, Onoguchi M. Patient arm position during quantitative bone single-photon emission computed tomography/computed tomography acquisition can affect image quality and quantitative accuracy: a phantom study. Nucl Med Commun. 2021;42:267–75.
doi: 10.1097/MNM.0000000000001338
Masuda Y, Nagaki A, Kawabuchi Y, Ohya N, Katafuchi T, Ttraoka S, et al. Point of acquisition, processing, display and output for standardized images with clinical usefulness. Jpn J nucl Med Tech. 2008;28:13–66.
Bailey DL, Willowson KP. An evidence-based review of quantitative SPECT imaging and potential clinical applications. J Nucl Med. 2013;54:83–9.
doi: 10.2967/jnumed.112.111476
Zacho HD, Manresa JAB, Aleksyniene R, Ejlersen JA, Fledelius J, Bertelsen H, et al. Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT. EJNMMI Res. 2017;7:1–7.
doi: 10.1186/s13550-016-0252-1
Tabotta F, Jreige M, Schaefer N, Becce F, Prior JO, Nicod LM. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases. BMC Musculoskelet Disord. 2019;20:1–7.
doi: 10.1186/s12891-019-3001-6
Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, et al. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res. 2006;12:6213–7.
doi: 10.1158/1078-0432.CCR-06-1007
Ichikawa H, Miwa K, Matsutomo N, Watanabe Y, Kato T, Shimada H. Development of a novel body phantom with bone equivalent density for evaluation of bone SPECT. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2015;71:1235–40.
doi: 10.6009/jjrt.2015_JSRT_71.12.1235

Auteurs

Shohei Fukai (S)

Department of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. syohei.fukai@jfcr.or.jp.
Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, 323-1 Kamioki-machi, Maebashi, Gunma, 371-0052, Japan. syohei.fukai@jfcr.or.jp.

Hiromitsu Daisaki (H)

Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, 323-1 Kamioki-machi, Maebashi, Gunma, 371-0052, Japan.
Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.

Takuro Umeda (T)

Department of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Naoki Shimada (N)

Department of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Noriaki Miyaji (N)

Department of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Ryoma Ito (R)

Department of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Tomohiro Takiguchi (T)

Department of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Takashi Terauchi (T)

Department of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH